CAS: 289483-69-8 - 3-Cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide
Formula:C17H12N4O2S
InChI:InChI=1/C17H12N4O2S/c1-11-5-6-15(17-16(11)13(9-19)10-20-17)21-24(22,23)14-4-2-3-12(7-14)8-18/h2-7,10,20-21H,1H3
- Synonyms:
- 3-Cyano-N-(3-cyano-4-methyl-1H-indole-7-yl)benzensulfonamide
- benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-
- E7820
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)- REF: IN-DA002X5NCAS: 289483-69-8 | 98% | To inquire | Tue 10 Dec 24 | |
E7820 REF: TM-T4435CAS: 289483-69-8 | 98.31% - 99.11% | 35.00 €~492.00 € | Tue 17 Dec 24 | |
E7820 REF: 3D-PLA48369CAS: 289483-69-8 | Min. 95% | - - - | Discontinued product |
Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-
CAS:289483-69-8
Formula:
C17H12N4O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
336.3678
Ref: IN-DA002X5N
1mg | 40.00 € | ||
5mg | 97.00 € | ||
10mg | 133.00 € | ||
25mg | 206.00 € | ||
50mg | 328.00 € | ||
100mg | 474.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
E7820
CAS:289483-69-8
E7820 (ER68203-00) is an angiogenesis inhibitor by suppressing integrin a2 (a cell adhesion molecule expressed …
Formula:
C17H12N4O2S
Purity:
98.31% - 99.11%
Color and Shape:
Solid
Molecular weight:
336.37
Ref: TM-T4435
1mg | 35.00 € | ||
2mg | 52.00 € | ||
5mg | 68.00 € | ||
10mg | 87.00 € | ||
25mg | 142.00 € | ||
50mg | 207.00 € | ||
100mg | 332.00 € | ||
200mg | 492.00 € | ||
1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
E7820
CAS:289483-69-8
E7820 is a drug that has been designed to inhibit the production of fibroblast-derived basic …
Formula:
C17H12N4O2S
Purity:
Min. 95%
Molecular weight:
336.37 g/mol
Ref: 3D-PLA48369
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |